|
Prophylactic Mastectomy
|
D000072036 |
[Surgical removal of one or both breasts to prevent or reduce the risk of developing breast cancer in persons who may be predisposed.
] |
|
Diagnosis-Related Groups
|
N03.219.521.710.305.200.080 |
|
|
Prospective Payment System
|
N03.219.521.710.305.200 |
|
|
Sertoli-Leydig Cell Tumor
|
C13.351.500.056.630.705.648 |
|
|
Cardiac Rehabilitation
|
D000072038 |
[Restoration of functions to the maximum degree possible in a person or persons suffering from a CARDIOVASCULAR DISEASE. It also includes cardiac conditioning and SECONDARY PREVENTION in patients with elevated cardiovascular risk profile.
] |
|
Fracture Dislocation
|
D000072039 |
[Fracture of a bone near an articulation with concomitant dislocation of that joint.
] |
|
Substance P
|
D23.469.050.375.850.890 |
|
|
Tachykinins
|
D23.469.050.375.850 |
|
|
Leukemia, Biphenotypic, Acute
|
C20.683.515.528.100 |
|
|
Tuberculosis, Multidrug-Resistant
|
C01.150.252.410.040.552.846.775 |
|
|
Scapegoating
|
F01.145.813.572 |
|
|
Tooth Exfoliation
|
G10.549.820 |
|
|
Ethics, Dental
|
K01.752.622.416 |
|
|
Philosophy, Dental
|
K01.752.622 |
|
|
Vesiculovirus
|
B04.820.480.937.750.900 |
|
|
Apolipoprotein A-V
|
D000072040 |
[A minor apolipoprotein that associates with HIGH-DENSITY LIPOPROTEINS (HDL), VERY-LOW-DENSITY LIPOPROTEINS (VLDL), and CHYLOMICRONS. It regulates levels of plasma TRIGLYCERIDES by activating APOLIPOPROTEIN C-II LIPOPROTEIN LIPASE and inhibiting hepatic VLDL triglyceride hydrolysis.
] |
|
PAX3 Transcription Factor
|
D000072041 |
[A paired box transcription factor that functions in CELL PROLIFERATION; CELL MIGRATION; and APOPTOSIS. It also is involved in MYOGENESIS and neural development. Mutations in the PAX3 gene are associated with WAARDENBURG SYNDROME TYPE 1.
] |
|
Niemann-Pick Disease, Type B
|
C18.452.584.687.803.730.750 |
|
|
Pregnancy Tests, Immunologic
|
E05.200.970.620 |
|
|
Pregnancy Tests
|
E05.200.970 |
|
